Il y a eu 50 transactions d'initiés récentes enregistrées pour Rani Therapeutics Holdings, Inc. (RANI), dont 29 achats et 18 ventes. Le total des achats d'initiés s'élève à $13.37M et le total des ventes d'initiés à $22.6M.
Les initiés notables ayant une activité récente comprennent Javadi Alireza, Imran Mir A, Bassan Abraham. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — RANI
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-18 |
Javadi Alireza |
Chief Technical Officer |
Inconnu |
159,000 |
$0.62 |
$98.07K |
- |
| 2025-10-23 |
Imran Mir A |
10 Percent Owner |
Achat Informatif |
2,083,334 |
$0.48 |
$1M |
2,083,334 |
| 2025-10-23 |
Bassan Abraham |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-10-23 |
Bassan Abraham |
Director |
Attribution de RSU |
100,000 |
$2.09 |
$209K |
100,000 |
| 2025-10-23 |
Bailey Vasudev Jaiprakash |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-10-23 |
Bailey Vasudev Jaiprakash |
Director |
Attribution de RSU |
100,000 |
$2.09 |
$209K |
100,000 |
| 2025-10-21 |
South Cone Investments Limited Partnership |
10 Percent Owner |
Vente Informative |
4,000,000 |
$2.77 |
$11.07M |
2,379,194 |
| 2025-10-20 |
South Cone Investments Limited Partnership |
10 Percent Owner |
Vente Informative |
1,923,000 |
$2.41 |
$4.64M |
6,379,194 |
| 2025-08-01 |
Mckinley Kate |
Chief Business Officer |
Attribution de RSU |
120,000 |
$0.53 |
$63.36K |
120,000 |
| 2025-05-28 |
Imran Mir A |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-28 |
Butel Jean Luc |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-28 |
Ausiello Dennis A |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-28 |
Nanavaty Maulik |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-28 |
Farquharson Andrew |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-28 |
Rometty Lisa Ann |
Director |
Attribution de RSU |
50,000 |
$0.62 |
$31K |
50,000 |
| 2025-05-23 |
Sanford Svai S |
Chief Financial Officer |
Attribution de RSU |
325,000 |
$0.62 |
$200.46K |
325,000 |
| 2025-05-23 |
Imran Talat |
Chief Executive Officer |
Attribution de RSU |
1,053,000 |
$0.62 |
$649.49K |
1,053,000 |
| 2025-05-23 |
Hashim Mir |
Chief Scientific Officer |
Attribution de RSU |
325,000 |
$0.62 |
$200.46K |
325,000 |
| 2025-05-23 |
Mckinley Kate |
Chief Business Officer |
Attribution de RSU |
325,000 |
$0.62 |
$200.46K |
325,000 |
| 2024-12-16 |
Imran Mir A |
Director |
Restitution d'Actions |
101,276 |
$2.84 |
$287.62K |
- |
| 2024-12-16 |
Debuono Laureen |
Director |
Restitution d'Actions |
18,875 |
$2.84 |
$53.61K |
- |
| 2024-12-16 |
Butel Jean Luc |
Director |
Restitution d'Actions |
18,875 |
$2.84 |
$53.61K |
- |
| 2024-12-16 |
Ausiello Dennis A |
Director |
Restitution d'Actions |
15,423 |
$2.84 |
$43.8K |
- |
| 2024-12-16 |
Nanavaty Maulik |
Director |
Restitution d'Actions |
15,423 |
$2.84 |
$43.8K |
- |
| 2024-12-16 |
Farquharson Andrew |
Director |
Restitution d'Actions |
101,276 |
$2.84 |
$287.62K |
- |
| 2024-12-16 |
Rometty Lisa Ann |
Director |
Restitution d'Actions |
17,708 |
$2.84 |
$50.29K |
- |
| 2024-12-13 |
Mckinley Kate |
Chief Business Officer |
Achat Informatif |
17,960 |
$1.67 |
$29.99K |
17,960 |
| 2024-12-09 |
Imran Talat |
Chief Executive Officer |
Achat Informatif |
10,296 |
$1.94 |
$19.97K |
494,751 |
| 2024-10-15 |
South Cone Investments Limited Partnership |
10 Percent Owner |
Vente Informative |
523,738 |
$3.26 |
$1.71M |
8,302,194 |
| 2024-05-29 |
Imran Mir A |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Debuono Laureen |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Butel Jean Luc |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Ausiello Dennis A |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Nanavaty Maulik |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Farquharson Andrew |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-05-29 |
Rometty Lisa Ann |
Director |
Attribution de RSU |
50,000 |
$5.00 |
$250K |
50,000 |
| 2024-03-21 |
Sanford Svai S |
Chief Financial Officer |
Attribution de RSU |
323,500 |
$3.60 |
$1.16M |
323,500 |
| 2024-03-21 |
Imran Talat |
Chief Executive Officer |
Attribution de RSU |
1,085,000 |
$3.60 |
$3.91M |
1,085,000 |
| 2024-03-21 |
Hashim Mir |
Chief Scientific Officer |
Attribution de RSU |
323,500 |
$3.60 |
$1.16M |
323,500 |
| 2024-03-21 |
Groen Eric |
General Counsel |
Attribution de RSU |
323,500 |
$3.60 |
$1.16M |
323,500 |
| 2024-03-21 |
Mckinley Kate |
Chief Business Officer |
Attribution de RSU |
323,500 |
$3.60 |
$1.16M |
323,500 |
| 2023-12-16 |
Imran Mir A |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Debuono Laureen |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Butel Jean Luc |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Ausiello Dennis A |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Nanavaty Maulik |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Sanford Svai S |
Chief Financial Officer |
Restitution d'Actions |
171,500 |
$5.44 |
$932.96K |
34,300 |
| 2023-12-16 |
Farquharson Andrew |
Director |
Restitution d'Actions |
101,276 |
$4.11 |
$416.24K |
- |
| 2023-12-16 |
Imran Talat |
Chief Executive Officer |
Attribution de RSU |
31,252 |
$2.84 |
$88.76K |
31,252 |
| 2023-12-16 |
Hashim Mir |
Chief Scientific Officer |
Restitution d'Actions |
171,500 |
$5.44 |
$932.96K |
34,300 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi